PCI Biotech Holding ASA (OSL:PCIB)
Norway · Delayed Price · Currency is NOK 0.2520
-0.0080 (-3.08%)
At close: Dec 5, 2025
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 9.41 million as of December 5, 2025. Its market cap has decreased by -81.08% in one year.
Market Cap
9.41M
Enterprise Value
-3.93M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 97.50M to 9.41M, a decrease of -90.35%. That is a compound annual growth rate of -12.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 9.41M | -78.79% |
| Dec 30, 2024 | 44.34M | -43.29% |
| Dec 29, 2023 | 78.20M | 2.20% |
| Dec 30, 2022 | 76.52M | -85.26% |
| Dec 30, 2021 | 519.21M | -50.14% |
| Dec 30, 2020 | 1.04B | -63.57% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.53B |
| Nordhealth AS | 2.91B |
| Photocure ASA | 1.76B |
| Thor Medical ASA | 1.49B |
| ArcticZymes Technologies ASA | 1.02B |
| Omda AS | 955.66M |
| Vistin Pharma ASA | 917.93M |
| Gentian Diagnostics ASA | 845.14M |